This inventor holds 5 USPTO granted patents and 7 published patent applications, plus 5 CIPO patents and 6 EPO patents. Top assignees: Abbvie Deutschland Gmbh and Co Kg, Abbvie Inc., Abbott Gmbh & Co Kg. Active years: 2012-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Schriescheim, DE (2019)
- Schriesheim, DE (2012 - 2022)
Company Filing History:
2 out of 167 
2 out of 826 
1 out of 140 
Years Active: 2012-2022
Title: Ulrich Westedt: Innovator in Pharmaceutical Compositions
Introduction
Ulrich Westedt is a notable inventor based in Schriesheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid pharmaceutical compositions. With a total of 5 patents to his name, Westedt's work has had a considerable impact on the treatment of various health conditions.
Latest Patents
One of Westedt's latest patents focuses on solid pharmaceutical compositions for treating HCV. This invention features solid pharmaceutical compositions that include Compound 1 and Compound 2. In one embodiment, the solid pharmaceutical composition consists of a first layer containing 100 mg of Compound 1, along with a pharmaceutically acceptable hydrophilic polymer and a surfactant, all formulated in amorphous solid dispersion. The second layer comprises 40 mg of Compound 2, also formulated in a similar manner. Another significant patent involves solid retard formulations based on solid dispersions. This formulation includes a melt-processed solid dispersion product that contains an active agent, a thermoplastic polymer of N-vinyl lactams, and a polyvinyl alcohol-polyalkylene glycol graft copolymer.
Career Highlights
Throughout his career, Ulrich Westedt has worked with prominent companies in the pharmaceutical industry, including AbbVie Deutschland GmbH & Co. KG and AbbVie Inc. His expertise in pharmaceutical formulations has positioned him as a valuable asset in the field.
Collaborations
Westedt has collaborated with notable professionals in the industry, including Harald Hach and Norbert Steiger. These collaborations have further enhanced his contributions to pharmaceutical innovations.
Conclusion
Ulrich Westedt's work in developing solid pharmaceutical compositions has made a significant impact on the treatment of diseases such as HCV. His innovative patents and collaborations with industry professionals highlight his dedication to advancing pharmaceutical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile